Literature DB >> 25101698

Glycemic control among individuals with self-reported diabetes in India--the ICMR-INDIAB Study.

Ranjit Unnikrishnan1, Ranjit Mohan Anjana, Mohan Deepa, Rajendra Pradeepa, Shashank R Joshi, Anil Bhansali, Vinay K Dhandania, Prashant P Joshi, Sri Venkata Madhu, Paturi Vishnupriya Rao, Ramakrishnan Lakshmy, Ramamurthy Jayashri, Kaliaperumal Velmurugan, Elangovan Nirmal, Radhakrishnan Subashini, Venkataraman Vijayachandrika, Tanvir Kaur, Deepak Kumar Shukla, Ashok Kumar Das, Viswanathan Mohan.   

Abstract

AIMS: This study estimated the levels of glycemic control among subjects with self-reported diabetes in urban and rural areas of four regions in India. RESEARCH DESIGN AND METHODS: Phase I of the Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) Study was conducted in a representative population of three states of India (Tamil Nadu, Maharashtra, and Jharkhand) and one Union Territory (Chandigarh) and covering a population of 213 million people. Using a stratified multistage sampling design, individuals ≥20 years of age were recruited. Glycemic control among subjects with self-reported diabetes was assessed by measurement of glycated hemoglobin (HbA1c), estimated by the Variant™ II Turbo method (Bio-Rad, Hercules, CA).
RESULTS: Among the 14,277 participants in Phase I of INDIAB, there were 480 subjects with self-reported diabetes (254 urban and 226 rural). The mean HbA1c levels were highest in Chandigarh (9.1±2.3%), followed by Tamil Nadu (8.2±2.0%), Jharkhand (8.2±2.4%), and Maharashtra (8.0±2.1%). Good glycemic control (HbA1c <7%) was observed only in 31.1% of urban and 30.8% of rural subjects. Only 22.4% of urban and 15.4% of rural subjects had reported having checked their HbA1c in the past year. Multiple logistic regression analysis revealed younger age, duration of diabetes, insulin use, and high triglyceride levels to be significantly associated with poor glycemic control.
CONCLUSIONS: The level of glycemic control among subjects with self-reported diabetes in India is poor. Urgent action is needed to remedy the situation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25101698      PMCID: PMC4135327          DOI: 10.1089/dia.2014.0018

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  20 in total

1.  European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults.

Authors:  Eoin O'Brien; Neil Atkins; George Stergiou; Nikos Karpettas; Gianfranco Parati; Roland Asmar; Yutaka Imai; Jiguang Wang; Thomas Mengden; Andrew Shennan
Journal:  Blood Press Monit       Date:  2010-02       Impact factor: 1.444

2.  Is glycemic control improving in U.S. adults?

Authors:  Thomas J Hoerger; Joel E Segel; Edward W Gregg; Jinan B Saaddine
Journal:  Diabetes Care       Date:  2007-10-12       Impact factor: 19.112

3.  The Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study: methodological details.

Authors:  Ranjit Mohan Anjana; Rajendra Pradeepa; Mohan Deepa; Manjula Datta; Vasudevan Sudha; Ranjit Unnikrishnan; Lalith M Nath; Ashok Kumar Das; Sri Venkata Madhu; Paturi Vishnupriya Rao; Deepak Kumar Shukla; Tanvir Kaur; Mohammed K Ali; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

4.  Prevalence and control of diabetes in Chinese adults.

Authors:  Yu Xu; Limin Wang; Jiang He; Yufang Bi; Mian Li; Tiange Wang; Linhong Wang; Yong Jiang; Meng Dai; Jieli Lu; Min Xu; Yichong Li; Nan Hu; Jianhong Li; Shengquan Mi; Chung-Shiuan Chen; Guangwei Li; Yiming Mu; Jiajun Zhao; Lingzhi Kong; Jialun Chen; Shenghan Lai; Weiqing Wang; Wenhua Zhao; Guang Ning
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

5.  Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus.

Authors:  C Fu; L Ji; W Wang; R Luan; W Chen; S Zhan; B Xu
Journal:  J Endocrinol Invest       Date:  2011-05-23       Impact factor: 4.256

6.  The status of diabetes control in Asia--a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998.

Authors:  L M Chuang; S T Tsai; B Y Huang; T Y Tai
Journal:  Diabet Med       Date:  2002-12       Impact factor: 4.359

7.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Glycaemic status and prevalence of comorbid conditions among people with diabetes in Kerala.

Authors:  V Usha Menon; U Guruprasad; K R Sundaram; R V Jayakumar; V Nair; H Kumar
Journal:  Natl Med J India       Date:  2008 May-Jun       Impact factor: 0.537

9.  Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young indians partly explained by hematological factors and iron deficiency anemia.

Authors:  Pallavi S Hardikar; Suyog M Joshi; Dattatray S Bhat; Deepa A Raut; Prachi A Katre; Himangi G Lubree; Abhay Jere; Anand N Pandit; Caroline H D Fall; Chittaranjan S Yajnik
Journal:  Diabetes Care       Date:  2012-02-08       Impact factor: 19.112

10.  The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.

Authors:  David M Nathan
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

View more
  29 in total

1.  Strategic Opportunities for Leveraging Low-cost, High-impact Technological Innovations to Promote Cardiovascular Health in India.

Authors:  Dorairaj Prabhakaran; Vamadevan S Ajay; Nikhil Tandon
Journal:  Ethn Dis       Date:  2019-02-21       Impact factor: 1.847

2.  Diabetes in the tropics: prevalent, increasing and a major public health problem.

Authors:  Ranjit Unnikrishnan; Viswanathan Mohan
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-05       Impact factor: 2.184

Review 3.  Diabetes mellitus and its complications in India.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Nat Rev Endocrinol       Date:  2016-04-15       Impact factor: 43.330

4.  The INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) study: Design and methods to address mental healthcare gaps in India.

Authors:  A J Kowalski; S Poongothai; L Chwastiak; M Hutcheson; N Tandon; R Khadgawat; G R Sridhar; S R Aravind; B Sosale; R M Anjana; D Rao; R Sagar; N Mehta; K M V Narayan; J Unutzer; W Katon; V Mohan; M K Ali
Journal:  Contemp Clin Trials       Date:  2017-06-19       Impact factor: 2.226

5.  Burden of Hypertension and Diabetes among Urban Population Aged ≥ 60 years in South Delhi: A Community Based Study.

Authors:  Anil Kumar Goswami; Sanjeev Kumar Gupta; Mani Kalaivani; Baridalyne Nongkynrih; Chandrakant S Pandav
Journal:  J Clin Diagn Res       Date:  2016-03-01

6.  Obesity paradigm in India: Are the consequences an impending Tsunami?

Authors:  Gautam Ahluwalia
Journal:  Indian J Med Res       Date:  2015-08       Impact factor: 2.375

7.  Short-term outcomes of type 2 diabetes mellitus patients treated with canagliflozin in real-world setting.

Authors:  Manash P Baruah; Sanjay Kalra
Journal:  Indian J Endocrinol Metab       Date:  2016 Jan-Feb

8.  The rule of two-thirds in diabetes epidemiology.

Authors:  Sanjay Kalra; Banshi Saboo; Rakesh Sahay; Deepak Khandelwal; Vipin Talwar; A G Unnikrishnan
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

9.  Treatment regimens and glycosylated hemoglobin levels in youth with Type 1 and Type 2 diabetes: Data from SEARCH (United States) and YDR (India) registries.

Authors:  Anandakumar Amutha; Pradeep A Praveen; Christine W Hockett; Toan C Ong; Elizabeth T Jensen; Scott P Isom; Ralph B Jr D'Agostino; Richard F Hamman; Elizabeth J Mayer-Davis; Raj Paul Wadwa; Jean M Lawrence; Catherine Pihoker; Michael G Kahn; Dana Dabelea; Nikhil Tandon; Viswanathan Mohan
Journal:  Pediatr Diabetes       Date:  2020-03-24       Impact factor: 3.409

10.  Baseline characteristics of participants in the LANDMARC trial: A 3-year, pan-india, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitus.

Authors:  Ashok K Das; Ambrish Mithal; Shashank Joshi; K M Prasanna Kumar; Sanjay Kalra; A G Unnikrishnan; Hemant Thacker; Bipin Sethi; Romik Ghosh; Vaishali Kanade; Arjun Nair; Senthilnathan Mohanasundaram; Shalini K Menon; Deepa Chodankar; Vaibhav Salvi; Chirag Trivedi; Godhuli Chatterjee; Subhankar Chowdhury; Nadeem Rais; Subhash K Wangnoo; Abdul H Zargar
Journal:  Endocrinol Diabetes Metab       Date:  2021-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.